Fierce Healthcare September 30, 2022
Methicillin-resistant Staphylococcus aureus (MRSA) is back with a vengeance.
Not that the staph infection that often keeps antibiotics at bay ever left during the COVID-19 pandemic. But its resurgence during the pandemic puts it at levels that eliminate all the gains made against it in the last decade, according to a study in Antimicrobial Resistance & Infection Control. The silver lining in this development might be that the playbook for containing MRSA still works well.
Veterans Health Administration (VHA) hospitals managed to keep MRSA infection rates at pre-pandemic levels.
“The third quarter of 2021, the Standardized Infection Ratio for hospital-onset MRSA bloodstream infections was 1.17, well above the baseline value of 1.0,” the study found. “In contrast, the...
Today's Sponsors
Today's Sponsor